We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 3% over five years while the S&P 500 rose 72%.
“U.S. Pediatric Nutritionals sales decreased 2.3 percent in 2025, primarily reflecting lower infant formula sales.”
| The company | Sales up 10% on the year |
| Latest filing | 10-Q, Nov 4 |
Abbott Plans to Spin Off Its Nutrition Business (ABT US)
A results day: the move is left out.
After its last 4 reports it closed -1.8% on average, higher 1 of 4 times.
Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. ABT scores 7 today, against a median of 3 over its last 20 recorded sessions.
ABT is #29 of 90 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 29 |
Expected to report Thu Jan 28, before the open (in 79 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $13.0B; a profit of $0.53 a share.
“Worldwide Nutrition results were driven by broad-based growth across the portfolio, including sales growth of nearly 9.0 percent in Worldwide Pediatric.”
| Line | Q3 2026 | Q3 2025 |
|---|---|---|
| Medical Devices | $5.8B | $5.4B |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 4)
| Measure | Figure |
|---|---|
| Comparable sales growth | about 6% |
Sales grew 5.1% a year over 5 years, fiscal 2020 to 2025.
Pays $2.52 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 21, 2026 | -1.1% | -1.9% | +0.6% |
| Jul 16, 2026 | +6.7% | +10.7% | +12.7% |
| Apr 16, 2026 | -4.4% | -6.0% | -9.7% |
Sales grew in six of the last seven years, to $44B in 2025. It made a profit in each of the eight years.
RSI 59.3, MACD above signal, above both averages. Not scored.
Its dividends come to 65% of its free cash flow.
| Dividend | $2.52 a share a year |
| Paid out | About $4.4B a year |
| Free cash flow | $6.8B |
| Record | Raised each of the last 5 years |
4 insiders sold $47.3M across 5 filings in the last 6 months. No open-market buys on record. The newest:
43 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: ABT is 4.6% of SCHD, 1.1% of DGRO, and 0.8% of VIG, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jul 31 to Aug 31, 2026.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
ABT scores 7 today, which Breakaway calls Average. It is #29 of 90 in Pharma by Quality Score, with 3 of 14 chart checks firing. Down 3% over five years while the S&P 500 rose 72%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
ABT scores 7 today, which Breakaway calls Average (6 to 10). That is #29 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ABT's 7.
4 insiders sold $47.3M across 5 filings in the last 6 months. No open-market buys on record. The newest is Mary K. Moreland, Executive Vice President, who sold $406K on Nov 5. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.